Research article · 30 Jun 2026
Conference abstractPublished 2018
What is new in management of recurrent pregnancy loss?
Benha University Hospital, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A diagnosis of RPL could be considered after the loss of two or more pregnancies Risk factors: Further research is needed before screening for endometritis can be recommended. No evidence that stress causes pregnancy loss (PL). It is unclear whether caffeine intake is a risk factor for PL. Investigations: 1. Sonohysterography is more accurate than HSG in diagnosing uterine malformations. It can be used to evaluate uterine morphology when 3D is not available. 2. It is not recommended to assess for PCOS, fasting insulin and fasting glucose, prolactin testing, Luteal phase insufficiency testing or measurement of homocysteine plasma levels. 3. It is not recommended to screen for inherited thrombophilia. 4. Genetic analyses of pregnancy tissue, parental karyotyping or ovarian reserve testing are not routinely recommended., measurement of anti-HY antibodies, NK cell testing, Antinuclear antibodies testing and assessing sperm DNA fragmentation can be considered. Thyroid screening (TSH and TPO-antibodies) is recommended. Treatment: If women with subclinical hypothyroidism or thyroid autoimmunity, TSH level should be checked in early gestation, and eventual hypothyroidism should be treated with levothyroxine. There is insufficient evidence to recommend the use of progesterone; use of hCG, metformin to improve live birth rate. Whether hysteroscopic septum resection has beneficial effects, should be evaluated in the context of surgical trials in women with RPL and septate uterus. Pituitary suppression before induction of ovulation in women with RPL and PCOS could be an option to reduce the risk of PL. Bromocriptine treatment is recommended in women with RPL and hyperprolactinemia. Preconception counseling in women with RPL could include the general advice to consider prophylactic vitamin D supplementation. There is no evidence supporting hysteroscopic removal of submucosal fibroids or endometrial polyps. Surgical removal of intramural fibroids is not recommended in women with RPL. There is insufficient evidence to recommend removing fibroids distorting the uterine cavity. There is insufficient evidence of benefit for surgical removal of intrauterine adhesions for pregnancy outcome. In unexplained RPL: antioxidants for men, IvIg, glucocorticoids, heparin or low dose aspirin, Low dose folic acid, vaginal progesterone, intralipid therapy, endometrial scratching does not improve live birth rate. There is insufficient evidence to recommended G-CSF in women with unexplained RPL.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Andrology & Gynecology: Current Research.
Editorial · 28 Mar 2025
Advances in Male Infertility Diagnosis and Treatment: A Contemporary Overview
Editorial · 28 Mar 2025
Advances in Urogenital Surgery: Minimally Invasive Techniques in Andrology and Gynecology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAndrology & Gynecology: Current Research
- SubjectNephrology & Urology
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Aboubakr Elnashar”
